These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 4620998)
1. d-LSD binding to brain homogenates: possible relationship to serotonin receptors. Bennett JL; Aghajanian GK Life Sci; 1974 Dec; 15(11):1935-44. PubMed ID: 4620998 [No Abstract] [Full Text] [Related]
2. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain. Hungen KV; Roberts S; Hill DF Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721 [TBL] [Abstract][Full Text] [Related]
3. Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function. Pettibone DJ; Pflueger AB J Neurochem; 1984 Jul; 43(1):83-90. PubMed ID: 6726257 [TBL] [Abstract][Full Text] [Related]
4. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. Sanders-Bush E; Burris KD; Knoth K J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634 [TBL] [Abstract][Full Text] [Related]
5. Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Pierce PA; Peroutka SJ Psychopharmacology (Berl); 1989; 97(1):118-22. PubMed ID: 2540505 [TBL] [Abstract][Full Text] [Related]
9. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity. Adams LM; Geyer MA Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):121-32. PubMed ID: 3858911 [TBL] [Abstract][Full Text] [Related]
10. 125I-LSD: a high sensitivity ligand for serotonin receptors. Hartig PR; Kadan MJ; Evans MJ; Krohn AM Eur J Pharmacol; 1983 May; 89(3-4):321-2. PubMed ID: 6873167 [No Abstract] [Full Text] [Related]
11. LSD mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility. Fink H; Oelssner W Eur J Pharmacol; 1981 Nov; 75(4):289-96. PubMed ID: 7318915 [TBL] [Abstract][Full Text] [Related]
12. LSD as an agonist and antagonist at central dopamine receptors. Von Hungen K; Roberts S; Hill DF Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522 [No Abstract] [Full Text] [Related]
13. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Glennon RA; Titeler M; McKenney JD Life Sci; 1984 Dec; 35(25):2505-11. PubMed ID: 6513725 [TBL] [Abstract][Full Text] [Related]
15. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors. Bennett JP; snyder SH Brain Res; 1975 Sep; 94(3):523-44. PubMed ID: 239784 [TBL] [Abstract][Full Text] [Related]
16. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei. Larson AA; Chinn C; Proudfit HK; Anderson EG J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778 [TBL] [Abstract][Full Text] [Related]
17. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines. Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591 [TBL] [Abstract][Full Text] [Related]
18. Neurotransmitter basis of the behavioral effects of hallucinogens. Rech RH; Commissaris RL Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241 [TBL] [Abstract][Full Text] [Related]
19. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat. Schoenfeld RI Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447 [TBL] [Abstract][Full Text] [Related]
20. The distribution of serotonin receptors in the human brain: high density of [3H]LSD binding sites in the raphe nuclei of the brainstem. Palacios JM; Probst A; Cortes R Brain Res; 1983 Sep; 274(1):150-5. PubMed ID: 6616253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]